Why do some people with hEDS or HSD report meaningful relief with medical cannabis, while others feel worse, notice no benefit, or experience side effects? And what might these varied responses teach us about pain, the autonomic nervous system, gut function, and nervous system sensitization? In this episode, host Dr. Linda Bluestein, the Hypermobility MD, is joined by Professor David Nutt, a neuropsychopharmacologist at Imperial College London, and Lucy Stafford, a PhD researcher in clinical neuroscience with lived experience of hypermobile Ehlers-Danlos syndrome. This is not a hype episode, a recommendation to use cannabis, or medical advice. Instead, it is a careful, curiosity-driven conversation about what is known, what is still emerging, and what remains uncertain about medical cannabis in hEDS and HSD. Lucy shares her experience of severe illness, high-dose opioid treatment, a feeding tube, repeated ICU stays, and eventually coming off opioids, an experience that helped shape her path into cannabinoid research. Professor Nutt explains the discovery of the endocannabinoid system and why this system may be relevant to pain processing, stress responses, autonomic regulation, immune signaling, and gut function. Together, they explore how cannabinoids may influence a sensitized nervous system, why responses vary so widely, and why medically complex patients need individualized guidance rather than shame, dismissal, or unsupported promises. The conversation covers many of the practical questions patients often ask, including the difference between CBD and THC, full-spectrum products, terpenes and the entourage effect, routes of administration, absorption differences, and the importance of a cautious “start low, go slow” approach when cannabis is being considered under appropriate medical supervision. They also address important safety considerations, including contraindications, drug interactions, psychiatric risk, impairment, dependence, and why cannabis is not appropriate for everyone. The episode closes with a broader discussion of stigma, the emerging science of psychedelics for chronic pain, and the human and financial costs of undertreated complex illness. The Bendy Bodies podcast is for educational purposes only and is not a substitute for personalized medical advice. Laws, product quality, dosing, and individual risks vary, so patients should consult a qualified healthcare professional before using cannabis or changing any treatment plan. Takeaways: The endocannabinoid system is an important regulatory system involved in pain processing, stress responses, immune signaling, gut function, and nervous system homeostasis, yet it receives relatively little attention in medical and neuroscience training. Cannabinoids do not work like opioids. Rather than simply “blocking” pain, they may influence pain modulation, nervous system sensitization, autonomic tone, and gut motility, though much remains to be studied specifically in hEDS and HSD. CBD and THC have different effects, benefits, and risks. CBD may reduce some unwanted THC effects for certain people, but responses vary, and dosing should be individualized. A cautious “start low, go slow” approach is especially important for medically complex patients, particularly those with dysautonomia, medication sensitivity, MCAS-like symptoms, anxiety, or multiple medications. Individual responses to cannabis vary widely. Differences in absorption, metabolism, product composition, route of administration, and underlying physiology may help explain why one person improves while another worsens or notices no effect. Cannabis is not right for everyone. Extra caution is warranted for people with a history of psychosis, paranoia, substance use disorder, significant cognitive impairment, fall risk, pregnancy, or medications metabolized through overlapping liver pathways. Patients deserve balanced information: neither stigma and dismissal nor exaggerated promises. The goal is thoughtful, evidence-informed, individualized decision-making. Go http://www.AquaTru.com now for 20% off (your purifier) using promo code BENDY. Head to http://www.cozyearth.com and use my code BENDY for an exclusive 20% off. Want more Professor Dave Nutt & Lucy Stafford? X / Twitter link. Profdavidnutt@twitter.com & @lucystaffie BleuSky:profdavidnutt@bluesky.com Instagram: @lustaffordphd, @drugscienceuk, @Drug_Science & @EmbodiedNeuro Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube: https://www.youtube.com/@bendybodiespodcast Instagram: https://www.instagram.com/hypermobilitymd/ Facebook: https://www.facebook.com/BendyBodiesPodcast X: https://twitter.com/BluesteinLinda LinkedIn: https://www.linkedin.com/in/hypermobilitymd/ Newsletter: https://hypermobilitymd.substack.com/ Shop my Amazon store https://www.amazon.com/shop/hypermobilitymd Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hypermobilitymd/store-start Want to learn more about the UVA EDS Center? For Appointments and Questions: RUVAEDSCenter@uvahealth.org UVA EDS: https://www.uvahealth.com/healthy-practice/advancing-care-through-ehlers-danlos-clinic UVA EDS FAQ: https://www.uvahealth.com/support/eds/faq UVA Pediatric Integrative Medicine: https://childrens.uvahealth.com/specialties/integrative-health Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at https://www\.bendybodiespodcast\.com/. YOUR bendy body is our highest priority! Learn more about Human Content at http://www\.human-content\.com Podcast Advertising/Business Inquiries: sales@human-content.com Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices
